Liver Diseases  >>  sunitinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sunitinib / Generic mfg.
NCT00361309: SU011248 in Advanced Hepatocellular Carcinoma

Checkmark P2 data
May 2011 - May 2011: P2 data
Completed
2
34
US
SU011248, Sunitinib
Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute
Hepatocellular Carcinoma, Liver Cancer
11/07
03/09
NCT00247676 / 2005-000525-30: An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Completed
2
37
Europe, RoW
Sunitinib (SU011248), SU011248, Sutent
Pfizer
Liver Neoplasms, Unresectable Hepatocellular Carcinoma
02/08
02/09
SAKK 77/06, NCT00514228 / 2007-003977-22: Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Completed
2
45
Europe
sunitinib malate, Sutent
Swiss Group for Clinical Cancer Research
Liver Cancer
08/08
02/09
NCT00787787: Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Terminated
2
41
US
sunitinib malate, SU11248, sunitinib, Sutent, capecitabine, CAPE, Ro 09-1978/000, Xeloda
University of Washington, National Cancer Institute (NCI)
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
04/10
06/10
NCT00806663 / 2008-001515-37: FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Completed
2
22
Europe
sunitinib added to FOLFIRI, Sutent
Central European Society for Anticancer Drug Research
Metastatic Colorectal Cancer, Liver Metastases
07/10
09/11
NCT00495625: Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Terminated
2
33
US
Sunitinib Malate, SU011248, Sutent
H. Lee Moffitt Cancer Center and Research Institute, Pfizer
Liver Cancer
12/10
12/10
Fibrolam, NCT01215565 / 2008-003423-23: Study of Sunitinib in Patients With Advanced/Inoperable ellar Carcinoma

Terminated
2
4
Europe
Sutent
Assistance Publique - Hôpitaux de Paris
Hepatocellular Carcinoma, Fibrolamellar Hepatocellular Carcinoma
05/11
05/12

Download Options